On November 21, 2022 Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, reported that company management will participate in fireside chats and 1×1 investor meetings at the 34th Annual Piper Sandler Healthcare Conference and the JMP Securities Hematology and Oncology Summit taking place on November 29 – December 1, 2022, and December 6 – 7, 2022, respectively (Press release, Cardiff Oncology, NOV 21, 2022, View Source [SID1234624362]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the fireside chats can be found below.
34th Annual Piper Sandler Healthcare Conference
Date:
Tuesday, November 29, 2022
Time:
1:30 – 1:55 PM ET
Conference Location:
New York, NY
Webcast Link:
The JMP Securities Hematology and Oncology Summit
Date:
Wednesday, December 7, 2022
Time:
3:00 – 3:15 PM ET
Conference Location:
Virtual
Webcast Link:
Wecast Link
Replays of the fireside chats will be available by visiting the "Events" section of the Cardiff Oncology website and will be archived for 90 days.